| Literature DB >> 32396705 |
Ashley N Beecy1, Alex Bratt2, Brian Yum1, Razia Sultana1, Mukund Das1, Ines Sherifi1, Richard B Devereux1, Jonathan W Weinsaft1, Jiwon Kim1.
Abstract
PURPOSE: Echocardiography (echo) is widely used for right ventricular (RV) assessment. Current techniques for RV evaluation require additional imaging and manual analysis; machine learning (ML) approaches have the potential to provide efficient, fully automated quantification of RV function.Entities:
Keywords: echocardiography; right ventricle; right ventricular function
Mesh:
Year: 2020 PMID: 32396705 PMCID: PMC7383774 DOI: 10.1111/echo.14674
Source DB: PubMed Journal: Echocardiography ISSN: 0742-2822 Impact factor: 1.724
FIGURE 1Network modules (A) and architecture schematic (B). Design of the network based on the U‐net architecture, which is widely used in medical segmentation tasks. Residual modules were employed to facilitate gradient flow during training and to prevent exploding/vanishing gradients. Horizontal lines between the contracting and expanding pathways of the network in (B) represent concatenation. Conv block = convolutional block; ReLU = rectified linear unit; Txp = transposed; Txp Conv Block = transposed convolutional block
Clinical characteristics
| Overall (n = 101) | RV dysfunction+ (n = 31) | RV dysfunction‐ (n = 70) |
| |
|---|---|---|---|---|
| Clinical | ||||
| Age (y) | 68 ± 10 | 69 ± 11 | 67 ± 10 | .38 |
| Male gender | 81% (82) | 87% (27) | 79% (55) | .31 |
| Body surface area | 1.9 ± 0.2 | 1.9 ± 0.2 | 2.0 ± 0.3 | .44 |
| Coronary artery disease risk factors | ||||
| Hypertension | 80% (81) | 68% (21) | 86% (60) | .04 |
| Hypercholesterolemia | 77% (78) | 68% (21) | 81% (57) | .13 |
| Diabetes mellitus | 51% (51) | 58% (18) | 47% (33) | .31 |
| Tobacco use | 62% (63) | 68% (21) | 60% (42) | .46 |
| Family history | 25% (25) | 23% (7) | 26% (18) | .74 |
| Prior myocardial infarction | 54% (54) | 61% (19) | 50% (35) | .29 |
| Prior coronary revascularization | 75% (76) | 81% (25) | 73% (51) | .40 |
| Percutaneous intervention | 55% (56) | 61% (19) | 53% (37) | .43 |
| Coronary artery bypass | 32% (32) | 32% (10) | 31% (22) | .93 |
Data presented as mean ± SD (data in parentheses refer to range for each respective variable). RV dysfunction: RVEF < 50%.
FIGURE 2Annular displacement measurements. Representative lateral and septal LTAD (left) and lateral and septal bidirectional CTAD (right). Segmentation performed both manually and by machine learning algorithm. CTAD = circumferential tricuspid annular displacement; LTAD = linear tricuspid annular displacement; RA = right atrium; RV = right ventricle
Imaging characteristics
| Overall (n = 101) | RV Dysfunction+ (n = 31) | RV Dysfunction− (n = 70) |
| |
|---|---|---|---|---|
| Cardiac morphology/function/tissue properties | ||||
| CMR (Left ventricle) | ||||
| Ejection fraction (%) | 42.6 ± 15.3 | 29.9 ± 9.2 | 48.3 ± 14.1 | <.001 |
| End‐diastolic volume (mL) | 201.9 ± 63.6 | 233.9 ± 58.3 | 187.8 ± 60.9 | .001 |
| End‐systolic volume (mL) | 122.0 ± 62.2 | 166.5 ± 53.0 | 102.3 ± 55.8 | <.001 |
| CMR (Right ventricle) | ||||
| Ejection fraction (%) | 52.4 ± 11.6 | 38.5 ± 8.0 | 58.7 ± 6.4 | <.001 |
| End‐diastolic volume (mL) | 151.2 ± 52.1 | 176.6 ± 57.2 | 139.8 ± 45.7 | .001 |
| End‐systolic volume (mL) | 75.1 ± 41.5 | 110.9 ± 49.0 | 59.0 ± 24.5 | <.001 |
| Echo (Left ventricle) | ||||
| Ejection fraction (%) | 41.8 ± 15.5 | 29.1 ± 9.0 | 47.5 ± 14.4 | <.001 |
| End‐diastolic diameter (cm) | 5.9 ± 0.6 | 6.2 ± 0.5 | 5.8 ± 0.6 | .001 |
| Pulmonary arterial pressure (mm Hg) | 38.5 ± 15.2 | 45.1 ± 16.0 | 35.3 ± 13.9 | .006 |
| Pulmonary hypertension | 42% (42) | 73% (19) | 43% (23) | .01 |
| Manual and machine learning‐derived RV function | ||||
| Manual | ||||
| Lateral | ||||
| LTAD (cm) | 3.2 ± 1.0 | 2.8 ± 0.8 | 3.4 ± 1.0 | <.001 |
| CTAD (cm) | 8.5 ± 3.2 | 7.4 ± 3.3 | 9.0 ± 3.0 | <.001 |
| Septal | ||||
| LTAD (cm) | 1.6 ± 0.6 | 1.3 ± 0.5 | 1.7 ± 0.6 | <.001 |
| CTAD (cm) | 4.9 ± 2.1 | 4.2 ± 2.1 | 5.3 ± 2.1 | <.001 |
| Machine learning | ||||
| Lateral | ||||
| LTAD (cm) | 3.1 ± 1.0 | 2.6 ± 0.7 | 3.3 ± 1.1 | <.001 |
| CTAD (cm) | 8.5 ± 4.0 | 7.0 ± 2.9 | 9.1 ± 4.3 | <.001 |
| Septal | ||||
| LTAD (cm) | 1.6 ± 0.9 | 1.2 ± 0.5 | 1.8 ± 1.0 | <.001 |
| CTAD (cm) | 4.5 ± 2.7 | 3.4 ± 1.6 | 4.9 ± 3.0 | <.001 |
| Conventional | ||||
| TAPSE (cm) | 1.8 ± 0.4 | 1.5 ± 0.3 | 1.9 ± 0.4 | <.001 |
| S′ (cm/s) | 11.2 ± 2.8 | 9.5 ± 2.4 | 12.0 ± 2.6 | <.001 |
| FAC (%) | 36.5 ± 10.4 | 29.3 ± 8.6 | 40.2 ± 9.4 | <.001 |
Data presented as mean ± SD (data in parentheses refer to range for each respective variable). RV dysfunction: RVEF < 50%.
Pulmonary hypertension defined as PASP > 35 mm Hg.
FIGURE 3Logistic regression and Bland–Altman analyses comparing automated and manual annular segmentation. Note good correlations (r = .61–.82) and reasonable limit of agreements for both LTAD and CTAD (LOA‐1.09‐1.39 and −5.3‐5.5, respectively). CTAD = circumferential tricuspid annular displacement; LTAD = linear tricuspid annular displacement
Reproducibility analysis for lateral annular displacement
| Mean ± SD [cm] | (LOA) [cm] | ICC |
| ||
|---|---|---|---|---|---|
| Inter‐observer | |||||
| LTAD | 0.30 ± 0.50 | (−0.68, 1.29) | 0.89 (0.73‐0.95) | <.001 | |
| CTAD | 0.52 ± 1.59 | (−2.41, 3.46) | 0.91 (0.84‐0.95) | <.001 | |
| Intra‐observer | |||||
| LTAD | −0.32 ± 0.55 | (−1.39, 0.75) | 0.87 (0.69‐0.93) | <.001 | |
| CTAD | −1.10 ± 1.71 | (−4.46, 2.26) | 0.88 (0.69‐0.94) | <.001 | |
FIGURE 4Tricuspid annular segmentation in relation to population‐based tertiles of TAPSE. As shown, both lateral and septal linear tricuspid annular displacement (left) as well as lateral and septal circumferential tricuspid annular displacement (right) decreased stepwise in relation to TAPSE strata. CTADL = lateral circumferential tricuspid annular displacement; CTADS = septal circumferential tricuspid annular displacement; LTADL = lateral linear tricuspid annular displacement; LTADS = septal linear tricuspid annular displacement
FIGURE 5Receiver operating characteristic curve for automated and conventional RV quantification in relation to RVEF < 50% as established reference standard of CMR. Note automated and conventional indices yielded similar diagnostic performance assessed as area under the curve. CMR = cardiac magnetic resonance; RV = right ventricle; RVEF = right ventricle ejection fraction
Test performance characteristics
| AUC (95% CI) | Cutoff (%) | Sensitivity (%) | Specificity (%) | Accuracy (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|---|---|---|
| Machine Learning | |||||||
| Lateral | |||||||
| LTAD | 0.69 (0.63‐0.76) | 3.41 | 84 | 44 | 56 | 40 | 86 |
| CTAD | 0.71 (0.64‐0.78) | 8.93 | 85 | 45 | 57 | 40 | 87 |
| Septal | |||||||
| LTAD | 0.75 (0.68‐0.82) | 1.75 | 83 | 39 | 52 | 37 | 84 |
| CTAD | 0.73 (0.66‐0.80) | 4.81 | 83 | 43 | 55 | 39 | 85 |
| Manual | |||||||
| Lateral | |||||||
| LTAD | 0.68 (0.61‐0.75) | 3.59 | 86 | 40 | 54 | 39 | 87 |
| CTAD | 0.70 (0.63‐0.78) | 9.59 | 86 | 40 | 54 | 39 | 87 |
| Septal | |||||||
| LTAD | 0.72 (0.65‐0.79) | 1.78 | 80 | 42 | 54 | 38 | 83 |
| CTAD | 0.70 (0.63‐0.78) | 5.61 | 81 | 40 | 52 | 37 | 83 |
| Conventional | |||||||
| TAPSE | 0.80 (0.73‐0.86) | 1.6 | 74 | 83 | 80 | 66 | 88 |
|
| 0.78 (0.71‐0.85) | 9.5 | 57 | 86 | 78 | 64 | 83 |